[Meta] proposal — a flair for hypoglycaemia posts
Genuinely asking, not being difficult.
Everyone in c/dosinglogs repeats that glycaemic control is important. I believe it, but I have never seen anyone show why, and when I search I get 4 threads of people agreeing with each other.
Is there a paper? Is there a measurement? Or is this one of those things that is true because it has been repeated since 2023?
I am not trying to be the "source?" guy. I would just like a source.
best — the order this archive was captured in
This is correct. Hypo risk is real.
Poland here. Waited 19 months on a list, gave up, went private, and the total cost was roughly what I expected.
Poland here.
Yes, exactly this, and it is the bit that took me 60 weeks to accept.
insulin and sulfonylurea interactions are real hypo risk
A1c, CGM, stacking with metformin
Yeah, glycaemic control is the original use.
That is net peptide content, not purity. Different number, different meaning.
Mechanistically the bit that matters is glycaemic control. It explains most of the early profile and a decent chunk of the outcome.
You have restated the marketing copy. What is the actual substance here.
That is net peptide content, not purity. Different number, different meaning.
glycaemic control first, that is the original indication
You have restated the marketing copy.
Adding to this: metformin is doing more work than the comment implies.
Came off after 27 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.
Maintenance for 13 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.
Did anything else change in the same window?
the UK here. Waited 9 months on a list, gave up, went private, and the total cost was roughly what I expected.
A1c, CGM, stacking with metformin
Yeah, glycaemic control is the original use.
The thing nobody prepared me for was the quiet. Not the appetite, the quiet. The constant negotiation in my head about food just stopped.
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
Removed a chain here. The rule is one line long and it is not negotiable.
- 1Mechanistically the bit that matters is glycaemic control. It explains most…6 comments in this branch · started by u/piotr_bruun
- 2This is correct. Hypo risk is real.5 comments in this branch · started by u/chain_confirm_c